CADTH Products

The Canadian Agency for Drugs and Technologies in Health (CADTH) produces a range of free products to inform and support those who make decisions about health policy and purchasing, service management, and clinical practice. If you are involved in health care delivery or decision-making, as a health care provider, educator, policy-maker, or consumer, here’s a snapshot of what we offer through our three core programs. Visit our program pages directly to access our products and to learn more about how they may be used. You can also visit our subscribe page to sign-up to receive our reports and newsletters.

Health Technology Assessment (HTA)
For information on impartial, rigorous, evidence-based assessments of the clinical effectiveness, cost-effectiveness, and broader impact of drugs, health technologies, and health systems.

Common Drug Review (CDR)
To find objective, rigorous reviews of the clinical and cost-effectiveness of drugs and formulary listing recommendations for Canada’s publicly funded drug plans.

Canadian Optimal Medication Prescribing and Utilization Service (COMPUS)

To access evidence-based, clinical and cost-effectiveness information on optimal drug prescribing and use, and to identify strategies, tools, and services that encourage the use of this information.